申请指南
为您找到最适合的专业与项目
学校动态
从学术会议、校企合作到学生实践与校园盛事,了解雷恩商学院的每日精彩。
我们的校区
雷恩和巴黎两大校区,为学生提供良好的学习与成长环境。
As founder of the biotechnology company Hemarina, Franck Zal has developed a universal oxygen carrier derived from the haemoglobin of a marine worm (Arenicola marina). This technology enables oxygen to be supplied to organs and tissues during storage and transport, thereby extending their shelf life prior to transplantation. It is already in use in the field of transplantation and is also being researched for other medical applications.
Visit the Hemarina website
As an entrepreneur, researcher and innovator, Franck Zal exemplifies the ability to transform a scientific discovery into a solution that addresses a major public health challenge. His journey demonstrates the impact that research, innovation and entrepreneurship can have when harnessed for the benefit of society.
The entire Rennes School of Business community extends its warmest congratulations to Franck Zal on this European recognition and is proud to count among its alumni an entrepreneur whose work helps to advance medical innovation.
Relive the 2026 European Inventor Awards